Industry Growth Insights published a new data on “Respiratory Syncytial Virus Diagnostics Market”. The research report is titled “Respiratory Syncytial Virus Diagnostics Market research by Types (Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Tests, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Other), By Applications (Hospitals, Laboratory, Clinics, Homecare), By Players/Companies Becton Dickinson, Abbott Laboratories, Abbott, Beckman Coulter/Danaher, Bio-Rad Laboratories, Coris BioConcept, DiaSorin SPA, Eiken Chemical, Elitech, Fujirebio, Grifols, Hoffmann La Roche, Hologic, Novartis Diagnostics, Ortho Clinical Diagnostics, Roche Diagnostics, Scienion”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Syncytial Virus Diagnostics Market Research Report
By Type
Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Tests, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Other
By Application
Hospitals, Laboratory, Clinics, Homecare
By Companies
Becton Dickinson, Abbott Laboratories, Abbott, Beckman Coulter/Danaher, Bio-Rad Laboratories, Coris BioConcept, DiaSorin SPA, Eiken Chemical, Elitech, Fujirebio, Grifols, Hoffmann La Roche, Hologic, Novartis Diagnostics, Ortho Clinical Diagnostics, Roche Diagnostics, Scienion
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Syncytial Virus Diagnostics Market Report Segments:
The global Respiratory Syncytial Virus Diagnostics market is segmented on the basis of:
Types
Direct Fluorescent Antibody Method, Rapid Antigen Diagnostic Tests, Molecular Diagnostics, Chromatographic Immunoassay, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Laboratory, Clinics, Homecare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton Dickinson
- Abbott Laboratories
- Abbott
- Beckman Coulter/Danaher
- Bio-Rad Laboratories
- Coris BioConcept
- DiaSorin SPA
- Eiken Chemical
- Elitech
- Fujirebio
- Grifols
- Hoffmann La Roche
- Hologic
- Novartis Diagnostics
- Ortho Clinical Diagnostics
- Roche Diagnostics
- Scienion
Highlights of The Respiratory Syncytial Virus Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct Fluorescent Antibody Method
- Rapid Antigen Diagnostic Tests
- Molecular Diagnostics
- Chromatographic Immunoassay
- Diagnostic Imaging
- Gel Microdroplets
- Flow Cytometry
- Other
- By Application:
- Hospitals
- Laboratory
- Clinics
- Homecare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Syncytial Virus Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory syncytial virus (RSV) is a respiratory infection caused by the RSV-A and RSV-B viruses. It is most commonly spread through contact with respiratory secretions, such as saliva or mucus, from an infected person. Symptoms of RSV include fever, cough, and shortness of breath. Diagnosis is made using a variety of methods including viral culture and serology (testing for antibodies against the virus). Treatment typically involves antibiotics to fight the infection.
Some of the key players operating in the respiratory syncytial virus diagnostics market are Becton Dickinson, Abbott Laboratories, Abbott, Beckman Coulter/Danaher, Bio-Rad Laboratories, Coris BioConcept, DiaSorin SPA, Eiken Chemical, Elitech, Fujirebio, Grifols, Hoffmann La Roche, Hologic, Novartis Diagnostics, Ortho Clinical Diagnostics, Roche Diagnostics, Scienion.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Syncytial Virus Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Syncytial Virus Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Syncytial Virus Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Syncytial Virus Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Syncytial Virus Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Respiratory Syncytial Virus Diagnostics Market Size and Y-o-Y Growth
4.5.2 Respiratory Syncytial Virus Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Respiratory Syncytial Virus Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Respiratory Syncytial Virus Diagnostics Market Size Forecast by Type
5.2.1 Direct Fluorescent Antibody Method
5.2.2 Rapid Antigen Diagnostic Tests
5.2.3 Molecular Diagnostics
5.2.4 Chromatographic Immunoassay
5.2.5 Diagnostic Imaging
5.2.6 Gel Microdroplets
5.2.7 Flow Cytometry
5.2.8 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Respiratory Syncytial Virus Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Respiratory Syncytial Virus Diagnostics Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Laboratory
6.2.3 Clinics
6.2.4 Homecare
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Syncytial Virus Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Syncytial Virus Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Respiratory Syncytial Virus Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Respiratory Syncytial Virus Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Respiratory Syncytial Virus Diagnostics Market Size Forecast by Type
9.6.1 Direct Fluorescent Antibody Method
9.6.2 Rapid Antigen Diagnostic Tests
9.6.3 Molecular Diagnostics
9.6.4 Chromatographic Immunoassay
9.6.5 Diagnostic Imaging
9.6.6 Gel Microdroplets
9.6.7 Flow Cytometry
9.6.8 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Respiratory Syncytial Virus Diagnostics Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Laboratory
9.10.3 Clinics
9.10.4 Homecare
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Respiratory Syncytial Virus Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Respiratory Syncytial Virus Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Respiratory Syncytial Virus Diagnostics Market Size Forecast by Type
10.6.1 Direct Fluorescent Antibody Method
10.6.2 Rapid Antigen Diagnostic Tests
10.6.3 Molecular Diagnostics
10.6.4 Chromatographic Immunoassay
10.6.5 Diagnostic Imaging
10.6.6 Gel Microdroplets
10.6.7 Flow Cytometry
10.6.8 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Respiratory Syncytial Virus Diagnostics Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Laboratory
10.10.3 Clinics
10.10.4 Homecare
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Respiratory Syncytial Virus Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size Forecast by Type
11.6.1 Direct Fluorescent Antibody Method
11.6.2 Rapid Antigen Diagnostic Tests
11.6.3 Molecular Diagnostics
11.6.4 Chromatographic Immunoassay
11.6.5 Diagnostic Imaging
11.6.6 Gel Microdroplets
11.6.7 Flow Cytometry
11.6.8 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Respiratory Syncytial Virus Diagnostics Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Laboratory
11.10.3 Clinics
11.10.4 Homecare
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Respiratory Syncytial Virus Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Respiratory Syncytial Virus Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Respiratory Syncytial Virus Diagnostics Market Size Forecast by Type
12.6.1 Direct Fluorescent Antibody Method
12.6.2 Rapid Antigen Diagnostic Tests
12.6.3 Molecular Diagnostics
12.6.4 Chromatographic Immunoassay
12.6.5 Diagnostic Imaging
12.6.6 Gel Microdroplets
12.6.7 Flow Cytometry
12.6.8 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Respiratory Syncytial Virus Diagnostics Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Laboratory
12.10.3 Clinics
12.10.4 Homecare
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Respiratory Syncytial Virus Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Respiratory Syncytial Virus Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Respiratory Syncytial Virus Diagnostics Market Size Forecast by Type
13.6.1 Direct Fluorescent Antibody Method
13.6.2 Rapid Antigen Diagnostic Tests
13.6.3 Molecular Diagnostics
13.6.4 Chromatographic Immunoassay
13.6.5 Diagnostic Imaging
13.6.6 Gel Microdroplets
13.6.7 Flow Cytometry
13.6.8 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Respiratory Syncytial Virus Diagnostics Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Laboratory
13.10.3 Clinics
13.10.4 Homecare
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Syncytial Virus Diagnostics Market: Competitive Dashboard
14.2 Global Respiratory Syncytial Virus Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton Dickinson
14.3.2 Abbott Laboratories
14.3.3 Abbott
14.3.4 Beckman Coulter/Danaher
14.3.5 Bio-Rad Laboratories
14.3.6 Coris BioConcept
14.3.7 DiaSorin SPA
14.3.8 Eiken Chemical
14.3.9 Elitech
14.3.10 Fujirebio
14.3.11 Grifols
14.3.12 Hoffmann La Roche
14.3.13 Hologic
14.3.14 Novartis Diagnostics
14.3.15 Ortho Clinical Diagnostics
14.3.16 Roche Diagnostics
14.3.17 Scienion
